Literature DB >> 19892662

Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Martha L Slattery1, F A Fitzpatrick.   

Abstract

Colorectal cancer (CRC) is a multifactorial disease with several hypothesized etiologic factors including inflammatory processes; hormones such as estrogen, androgen, and insulin; and energy-related factors. We present evidence that integrates these elements in a pathway we call the convergence of hormones, inflammation, and energy-related factors (CHIEF). First, given the physiology of the gut, substantial epidemiologic and molecular data support the hypothesis that activation of innate immunity in the normal gut mucosa by various environmental agents (commensal bacteria, dietary antigens, mucosal irritants, pathogens) and endogenous factors such as estrogen, androgens, and insulin levels provokes basal inflammation as an underlying factor of the association of insulin, estrogen, and energy-related factors with CRC. Second, critical genes involved in this pathway, e.g., phosphatase tensin homologue on chromosome 10 (PTEN) and serine threonine kinase 11 (STK11)/LKB1, are tumor suppressor genes often mutated in intestinal cancer or CRC. Third, laboratory experiments show that cellular PTEN and STK11/LKB1 tumor suppressor enzymes are vulnerable to inactivation by redox-active species, especially chemically reactive lipid mediators of inflammation and redox stress. Epidemiologic data further support the underlying proposal that CHIEF comprises important elements of CRC risk. Although this discussion of the CHIEF pathway focuses on CRC, we believe that this pathway may play an important role in the etiology of other cancers as well.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892662      PMCID: PMC2895421          DOI: 10.1158/1940-6207.CAPR-08-0191

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  124 in total

1.  Cytokine milieu tends toward inflammation in type 2 diabetes.

Authors:  Katherine Esposito; Francesco Nappo; Francesco Giugliano; Carmen Di Palo; Myriam Ciotola; Michelangela Barbieri; Giuseppe Paolisso; Dario Giugliano
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

Review 2.  Cytokine-related aging process.

Authors:  John E Morley; Richard N Baumgartner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-09       Impact factor: 6.053

3.  Stromal eosinophilia in colonic epithelial neoplasms.

Authors:  J Moezzi; N Gopalswamy; R J Haas; R J Markert; S Suryaprasad; M S Bhutani
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 4.  The role of TNFalpha and TNF receptors in obesity and insulin resistance.

Authors:  G S Hotamisligil
Journal:  J Intern Med       Date:  1999-06       Impact factor: 8.989

5.  Does nonsteroidal anti-inflammatory drug use modify the effect of a low-fat, high-fiber diet on recurrence of colorectal adenomas?

Authors:  Terryl J Hartman; Binbing Yu; Paul S Albert; Martha L Slattery; Electra Paskett; James Walter Kikendall; Frank Iber; Brenda K Brewer; Arthur Schatzkin; Elaine Lanza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

6.  Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer.

Authors:  L Le Marchand; L R Wilkens; L N Kolonel; J H Hankin; L C Lyu
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

7.  Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status.

Authors:  Giovanni Mantovani; Antonio Macciò; Clelia Madeddu; Loredana Mura; Giulia Gramignano; Maria Rita Lusso; Carlo Mulas; Maria Caterina Mudu; Viviana Murgia; Paolo Camboni; Elena Massa; Luca Ferreli; Paolo Contu; Augusto Rinaldi; Enrico Sanjust; Davide Atzei; Bernhard Elsener
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

Review 8.  Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

Authors:  B Viollet; F Andreelli; S B Jørgensen; C Perrin; D Flamez; J Mu; J F P Wojtaszewski; F C Schuit; M Birnbaum; E Richter; R Burcelin; S Vaulont
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

9.  Involvement of NF-kappaB in TGF-beta-mediated suppression of IL-4 signaling.

Authors:  Tetsuya Yamamoto; Seiyu Imoto; Yuichi Sekine; Kenji Sugiyama; Toshihiko Akimoto; Atsushi Muraguchi; Tadashi Matsuda
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

10.  Changing population characteristics, effect-measure modification, and cancer risk factor identification.

Authors:  Martha L Slattery; Maureen A Murtaugh; Charles Quesenberry; Bette J Caan; Sandra Edwards; Carol Sweeney
Journal:  Epidemiol Perspect Innov       Date:  2007-10-01
View more
  42 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Susan A Kadlubar; Kristina L Bondurant; Roger K Wolff
Journal:  Mol Carcinog       Date:  2011-11-28       Impact factor: 4.784

3.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: symbionts and immunopathology in chronic diseases: insights from evolution.

Authors:  P W Ewald
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

4.  Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes.

Authors:  Martha L Slattery; Abbie Lundgreen; Bill Welbourn; Roger K Wolff; Christopher Corcoran
Journal:  Mutat Res       Date:  2012-04-15       Impact factor: 2.433

Review 5.  Targeting mTOR network in colorectal cancer therapy.

Authors:  Xiao-Wen Wang; Yan-Jie Zhang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

Authors:  Martha L Slattery; Jennifer S Herrick; Abbie Lundgreen; Francis A Fitzpatrick; Karen Curtin; Roger K Wolff
Journal:  Carcinogenesis       Date:  2010-07-09       Impact factor: 4.944

7.  Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality.

Authors:  Martha L Slattery; Abbie Lundgreen; Lila E Mullany; Rosalind B Penney; Roger K Wolff
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

Review 8.  Exercise in patients coping with breast cancer: An overview.

Authors:  Sibel Eyigor; Selcen Kanyilmaz
Journal:  World J Clin Oncol       Date:  2014-08-10

9.  Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort.

Authors:  Joshua W Miller; Shirley A A Beresford; Marian L Neuhouser; Ting-Yuan David Cheng; Xiaoling Song; Elissa C Brown; Yingye Zheng; Beatriz Rodriguez; Ralph Green; Cornelia M Ulrich
Journal:  Am J Clin Nutr       Date:  2013-02-20       Impact factor: 7.045

10.  Genes, environment and gene expression in colon tissue: a pathway approach to determining functionality.

Authors:  Martha L Slattery; Daniel F Pellatt; Roger K Wolff; Abbie Lundgreen
Journal:  Int J Mol Epidemiol Genet       Date:  2016-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.